Annual CFI
$10.74 M
+$22.10 M+194.58%
31 December 2023
Summary:
Lumos Pharma annual cash flow from investing activities is currently $10.74 million, with the most recent change of +$22.10 million (+194.58%) on 31 December 2023. During the last 3 years, it has fallen by -$15.23 million (-58.64%).LUMO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Lumos Pharma quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$6.17 million (-100.00%).LUMO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$7.17 M
-$5.95 M-45.34%
30 September 2024
Summary:
Lumos Pharma TTM cash flow from investing activities is currently $7.17 million, with the most recent change of -$5.95 million (-45.34%) on 30 September 2024. Over the past year, it has dropped by -$3.57 million (-33.23%).LUMO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LUMO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -100.0% | -33.2% |
| 3 y3 years | -58.6% | +100.0% | -72.4% |
| 5 y5 years | +10000.0% | +100.0% | +10000.0% |
LUMO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -90.8% | -100.0% | -93.9% |
Lumos Pharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | $7.17 M(-45.3%) |
| June 2024 | - | $0.00(-100.0%) | $13.12 M(-7.6%) |
| Mar 2024 | - | $1.00 M(-83.8%) | $14.21 M(+32.2%) |
| Dec 2023 | $10.74 M(-194.6%) | $6.17 M(+3.7%) | $10.74 M(-258.2%) |
| Sept 2023 | - | $5.95 M(+449.4%) | -$6.79 M(-46.7%) |
| June 2023 | - | $1.08 M(-144.0%) | -$12.74 M(-7.8%) |
| Mar 2023 | - | -$2.46 M(-78.3%) | -$13.82 M(+21.7%) |
| Dec 2022 | -$11.36 M(-143.7%) | -$11.36 M(<-9900.0%) | -$11.36 M(>+9900.0%) |
| Sept 2022 | - | $0.00(0.0%) | -$30.00 K(0.0%) |
| June 2022 | - | $0.00(0.0%) | -$30.00 K(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | -$30.00 K(-100.1%) |
| Dec 2021 | $25.97 M(-77.7%) | -$30.00 K(<-9900.0%) | $25.97 M(-0.1%) |
| Sept 2021 | - | $0.00(0.0%) | $25.99 M(-55.6%) |
| June 2021 | - | $0.00(-100.0%) | $58.48 M(+0.0%) |
| Mar 2021 | - | $26.00 M(<-9900.0%) | $58.47 M(-49.9%) |
| Dec 2020 | $116.65 M(<-9900.0%) | -$12.00 K(-100.0%) | $116.65 M(-0.0%) |
| Sept 2020 | - | $32.50 M(<-9900.0%) | $116.66 M(+38.6%) |
| June 2020 | - | -$14.00 K(-100.0%) | $84.16 M(-0.0%) |
| Mar 2020 | - | $84.18 M(<-9900.0%) | $84.18 M(<-9900.0%) |
| Dec 2019 | -$2000.00(-101.7%) | -$2000.00(<-9900.0%) | -$2000.00(-133.3%) |
| Sept 2019 | - | $0.00(0.0%) | $6000.00(-62.5%) |
| June 2019 | - | $0.00(0.0%) | $16.00 K(-52.9%) |
| Mar 2019 | - | $0.00(-100.0%) | $34.00 K(-70.9%) |
| Dec 2018 | $117.00 K(-44.5%) | $6000.00(-40.0%) | $117.00 K(-35.0%) |
| Sept 2018 | - | $10.00 K(-44.4%) | $180.00 K(-8.6%) |
| June 2018 | - | $18.00 K(-78.3%) | $197.00 K(-35.8%) |
| Mar 2018 | - | $83.00 K(+20.3%) | $307.00 K(+45.5%) |
| Dec 2017 | $211.00 K | $69.00 K(+155.6%) | $211.00 K(-702.9%) |
| Sept 2017 | - | $27.00 K(-78.9%) | -$35.00 K(-76.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | - | $128.00 K(-1084.6%) | -$147.00 K(-85.0%) |
| Mar 2017 | - | -$13.00 K(-92.7%) | -$981.00 K(+1386.4%) |
| Dec 2016 | -$66.00 K(-101.1%) | -$177.00 K(+108.2%) | -$66.00 K(-111.0%) |
| Sept 2016 | - | -$85.00 K(-88.0%) | $602.00 K(+52.0%) |
| June 2016 | - | -$706.00 K(-178.3%) | $396.00 K(-87.8%) |
| Mar 2016 | - | $902.00 K(+83.7%) | $3.23 M(-48.0%) |
| Dec 2015 | $6.22 M(-144.9%) | $491.00 K(-268.7%) | $6.22 M(-35.3%) |
| Sept 2015 | - | -$291.00 K(-113.6%) | $9.61 M(-227.7%) |
| June 2015 | - | $2.13 M(-45.1%) | -$7.53 M(-23.7%) |
| Mar 2015 | - | $3.88 M(-0.1%) | -$9.87 M(-28.7%) |
| Dec 2014 | -$13.84 M(+9718.4%) | $3.89 M(-122.3%) | -$13.84 M(-23.5%) |
| Sept 2014 | - | -$17.43 M(+8446.1%) | -$18.09 M(+1183.6%) |
| June 2014 | - | -$204.00 K(+119.4%) | -$1.41 M(+53.3%) |
| Mar 2014 | - | -$93.00 K(-73.8%) | -$919.00 K(+551.8%) |
| Dec 2013 | -$141.00 K(-49.1%) | -$355.00 K(-53.1%) | -$141.00 K(-111.1%) |
| Sept 2013 | - | -$757.00 K(-364.7%) | $1.27 M(+8386.7%) |
| June 2013 | - | $286.00 K(-58.2%) | $15.00 K(-98.6%) |
| Mar 2013 | - | $685.00 K(-35.3%) | $1.07 M(-485.2%) |
| Dec 2012 | -$277.00 K(-44.8%) | $1.06 M(-152.6%) | -$277.00 K(-93.1%) |
| Sept 2012 | - | -$2.02 M(-250.6%) | -$4.01 M(+124.4%) |
| June 2012 | - | $1.34 M(-303.0%) | -$1.79 M(+29.4%) |
| Mar 2012 | - | -$659.00 K(-75.4%) | -$1.38 M(+175.3%) |
| Dec 2011 | -$502.00 K(-81.5%) | -$2.68 M(-1374.8%) | -$502.00 K(-123.1%) |
| Sept 2011 | - | $210.00 K(-88.0%) | $2.17 M(+10.7%) |
| June 2011 | - | $1.74 M(+689.1%) | $1.97 M(+789.1%) |
| Mar 2011 | - | $221.00 K | $221.00 K |
| Dec 2010 | -$2.71 M(+75.3%) | - | - |
| Dec 2009 | -$1.54 M(-50.6%) | - | - |
| Dec 2008 | -$3.13 M | - | - |
FAQ
- What is Lumos Pharma annual cash flow from investing activities?
- What is the all time high annual CFI for Lumos Pharma?
- What is Lumos Pharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Lumos Pharma?
- What is Lumos Pharma quarterly CFI year-on-year change?
- What is Lumos Pharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for Lumos Pharma?
- What is Lumos Pharma TTM CFI year-on-year change?
What is Lumos Pharma annual cash flow from investing activities?
The current annual CFI of LUMO is $10.74 M
What is the all time high annual CFI for Lumos Pharma?
Lumos Pharma all-time high annual cash flow from investing activities is $116.65 M
What is Lumos Pharma quarterly cash flow from investing activities?
The current quarterly CFI of LUMO is $0.00
What is the all time high quarterly CFI for Lumos Pharma?
Lumos Pharma all-time high quarterly cash flow from investing activities is $84.18 M
What is Lumos Pharma quarterly CFI year-on-year change?
Over the past year, LUMO quarterly cash flow from investing activities has changed by -$6.17 M (-100.00%)
What is Lumos Pharma TTM cash flow from investing activities?
The current TTM CFI of LUMO is $7.17 M
What is the all time high TTM CFI for Lumos Pharma?
Lumos Pharma all-time high TTM cash flow from investing activities is $116.66 M
What is Lumos Pharma TTM CFI year-on-year change?
Over the past year, LUMO TTM cash flow from investing activities has changed by -$3.57 M (-33.23%)